DiagnaMed Holdings Corp. · CSE:DMED
DiagnaMed — Investor Presentation (May 2023)
16 slides from DiagnaMed's investor presentation, May 2023
Slide 1: Generative AI Healthcare Solutions Corporate Presentation
Generative AI Corporate Presentation May 2023 Healthcare Solutions DiagnaMed Holdings Corp. 82 Richmond Street East Toronto, ON M5C 1P1 e. info@diagnamed.com t. 416-800-2684
Slide 2: Forward-Looking Statements
This presentation of DiagnaMed Holdings Corp. (“DiagnaMed”) contains "forward- looking information", which may include, but is not limited to, statements with respect to anticipated business plans or strategies of DiagnaMed, the anticipated date of completion of product developments, the timing of a
Slide 3: Our Platforms: Commercializing Generative AI Healthcare Solutions
Our Platforms Commercializing Generative AI CERVAI™ Generative AI Brain Health Platform Healthcare Solutions HEALTH GPT Generative AI Healthcare Applications CSE: DMED | OTCQB: DGNMF
Slide 4: CERVAI Generative AI Brain Health Platform
CERVAI™ Generative AI Brain Health Platform CSE: DMED | OTCQB: DGNMF
Slide 5: Digital Brain Health Market over $375 Billion by 2031
+1 Billion Digital Brain Mental Health Depression, PTSD, Anxiety, etc Health Market over $375 Billion +1 Billon by 2031* Neurodegenerative Parkinson's, Alzheimer's, Brain injury, Dementia, *Source: TMR Report https://www.prnewswire.com/news- releases/digital-brain-health-market-to-exceed-value-of- C
Slide 6: Problem
Problem I have a family history of Alzheimer's There is no one-fits-all solution I'm feeling depressed for estimating, monitoring and I keep on forgetting things improving brain health. Expensive equipment and unproven intervention methods must be more reliable and scalable. CSE: DMED | OTCQB: DGNMF
Slide 7: Solution CERVAI
Solution Brain Age Brain Health Estimation Score Use of a novel Evaluate overall brain electroencephalogram health, output a patient (EEG) device and ML/AI risk score, and provide technique for predicting actionable data powered and monitoring brain age. by GPT. Brain Health CERVAI™ Brain Disorder G
Slide 8: CERVAI Journey
CERVAI™ Journey 1 How old is my brain? 2 3 1 2 3 TAKING CONTROL ESTIMATING BRAIN AGE BRAIN HEALTH REPORT Curious, depressed, neuro disorder, Schedule a visit to a CERVAI™ Report with estimated brain age family history, provider and brain health assessment 4 5 6 5 5 NEXT STEPS FOR BRAIN HEALTH EARLY
Slide 9: Business Model CERVAI
Business Model License Fees Place in up to 25,000 provider locations in North America (Primary care physicians, psychiatric & neurology clinics, senior care homes, pharmacies) Recurring Visits Patient programs offered 2-12 visits per year App Subscriptions Monthly subscription to virtual clinic digi
Slide 10: Commercial Pathway
Commercial Pathway 2024 H2-2023 H1-2023 Unlock new uses of CERVAI™ Commercialize Clinical diagnostic tool for CERVAI™ monitoring and screening of mental health, neurological and Grow provider sites, consumer brain injuries Establish CERVAI™ provider and patient awareness network Licensed physicians
Slide 11: Partnerships
Partnerships Brain Age Brain Health Development Development CSE: DMED | OTCQB: DGNMF
Slide 12: HEALTH GPT Generative AI Healthcare Applications
HEALTH GPT Generative AI Healthcare Applications CSE: DMED | OTCQB: DGNMF
Slide 13: Generative AI in the healthcare market to reach USD billion by 2032
Generative AI in the healthcare market to reach ~ USD 17 billion by 2032* *Source: Market.us https://www.globenewswire.com/news- release/2023/04/03/2639957/0/en/Generative-AI-in- Healthcare-Market-Set-to-Reach-a-Valuation-of-USD-17-2- CSE: DMED | OTCQB: DGNMF Bn-by-2032-Data-Analysis-by-Experts-at-M
Slide 14: Leveraging our experience in building generative AI applications to healthcare
Leveraging our experience in building generative AI HEALTH GPT Generative AI applications to Healthcare Applications complement CERVAI™ Launched In-development and the unmet needs FORM GPT Dr. GENAI of the healthcare Healthcare providers to create forms powered by ChatGPT Enabling patients and pract
Slide 15: Team
Team Management & Advisors Board of Directors Fabio Chianelli Fabio Chianelli Chairman, CEO ,Chairman, CEO Founder, CEO - PharmaTher Founder, CEO - PharmaTher Founder, President - Revive Therapeutics Founder, President - Revive Therapeutics Dr. Bassma Ghali, PhD Ming Jang, CPA, CGA VP, Product Chief
Slide 16: Capital Structure
Capital 78,392,640 15,090,000 Common Shares outstanding Warrants outstanding Structure 2,000,000 ~ 21% Stock Options outstanding Insiders Ownership 44,702,085 Common Shares and 15,250,000 Warrants (expires May 10, 2023) are subject to escrow 1/10th released at listing (November 8, 2022) 1/10th relea
DiagnaMed Holdings — Investor Presentation (May 2023) on 6ix